About this item
Product details
Diampa LXR is a triple-combination oral medication for the management of type 2 diabetes in adults. This formulation provides a balanced and effective approach by combining a lower 5mg dose of Empagliflozin (an SGLT2 inhibitor) with Linagliptin 2.5mg (a DPP-4 inhibitor) and a full 1000mg dose of Metformin (a biguanide). It is designed for patients requiring multi-mechanism glucose control with the added benefits of cardiovascular protection, kidney benefits, and weight management support, all in a single once-daily tablet. Multi-Targeted Glucose Control: Works through three pathways (urinary glucose excretion, insulin release, reduced liver glucose) for effective blood sugar management. Cardiovascular & Kidney Support: Empagliflozin provides protective benefits for the heart and kidneys, even at lower doses. Convenient Regimen: Simplifies therapy by combining three medications into one daily pill, improving treatment adherence. Weight-Friendly: May support weight loss or weight maintenance as part of diabetes management. Composition Each film-coated tablet contains: Empagliflozin: 5 mg Linagliptin: 2.5 mg Metformin HCI USP: 1000 mg (as extended release) Directions for Use As directed by the physician.
- Medicines
- 14 Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 08964003891626
- Variant
- 14 Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
